Investment Rating - The report does not provide a specific investment rating for NCE Power (605111.SS) as it is categorized as "Not Covered" [1]. Core Insights - NCE Power anticipates a recovery in demand for power semiconductors, driven by improving inventory levels and foundries' utilization rates, with management expressing optimism for sales growth in 2025 [4][6]. - The company is facing significant competition from both domestic and international peers, alongside tariff uncertainties that may impact future demand [6][7]. - NCE Power is focusing on expanding into higher-end applications, particularly in the automotive sector with 800V and 48V EV platforms, as well as emerging markets such as drones, eVTOL, and AI computing [7]. Summary by Sections Demand Recovery - Management reports a recovering trend in power semiconductors since last year, with inventory improvements and foundries nearing full capacity [4]. - The overall outlook for power semiconductors is positive, with expectations for increased sales growth in 2025 [4]. Competitive Landscape - There is ongoing competition among domestic and overseas peers, which poses challenges for NCE Power [6]. - Tariff risks are also highlighted as a source of uncertainty for future demand [6]. Strategic Expansion - NCE Power is expanding its product offerings into broader and higher-end applications, with a strong focus on automotive electronics [7]. - The company aims to accelerate product adoption in 800V and 48V EV platforms, while also exploring growth in industrial control applications such as drones and robotics [7].

Investment Rating - The report does not provide a specific investment rating for SenseTime (0020.HK) [3] Core Insights - SenseTime's management is optimistic about the generative AI trend in China and has launched a new foundation model, SenseNova V6, which features competitive costs for training and inferencing [1][7] - The company signed a Memorandum of Understanding (MOU) with the Faculty of Law at the Chinese University of Hong Kong to enhance legal information accessibility through AI [4][6] - The generative AI trend is expected to benefit the broader China AI supply chain, with more companies willing to adopt generative AI technologies [2] Company Profile - SenseTime is a leading AI software company that provides capabilities in multimodal and multi-task models, covering areas such as perception intelligence, natural language processing, and AI-enabled content generation [3] - The SenseCore platform integrates computing power, algorithms, and platforms to create the SenseNova foundation model set, enabling efficient general AI tasks at low costs [3] Key Takeaways - The SenseNova V6 model introduced by SenseTime has multimodal reasoning capabilities and cost efficiency in both training and inferencing, supporting various applications such as role-playing, translation, and long-form video understanding [7] - The collaboration with the Faculty of Law aims to digitally transform legal information provision in Hong Kong, promoting broader access to legal information [6]

Investment Rating - The report upgrades FLSmidth to a Buy rating from Neutral, with a 12-month price target increased to DKK 430 from DKK 340, indicating an upside potential of 17.9% [1]. Core Insights - The report highlights that FLSmidth is expected to improve its margins by +320 basis points to 14.2% by 2027, driven by SG&A savings and a higher mix of service and PCV [1]. - The current EV/EBIT multiple of 9.9x is below its 10-year median of 11.5x, suggesting a re-rating is warranted as the company enhances its margin prospects [1]. - FLSmidth is in exclusive negotiations to divest its Cement business, which could act as a catalyst for a re-rating as it transitions to a pure-play mining business [1]. - The company anticipates a gradual increase in orders, forecasting group orders to be +0.3%/+0.7%/+1.8% above consensus for FY25/26/27 [1]. Financial Projections - Revenue projections for FLSmidth are DKK 20,187 million for FY24, DKK 18,683.9 million for FY25, DKK 19,341.2 million for FY26, and DKK 20,269.9 million for FY27 [2]. - Adjusted EBIT estimates are projected to be DKK 1,998.5 million for FY24, DKK 2,271.3 million for FY25, DKK 2,419.7 million for FY26, and DKK 2,642.5 million for FY27 [2]. - EPS is expected to grow from DKK 22.51 in FY24 to DKK 32.50 in FY27, reflecting a positive growth trajectory [2]. Valuation Metrics - The report provides various valuation ratios, including a P/E ratio of 15.3x for FY24, decreasing to 11.2x by FY27, indicating an attractive valuation as earnings grow [7]. - The dividend yield is projected to increase from 2.3% in FY24 to 3.6% in FY27, suggesting a commitment to returning capital to shareholders [7]. - The report notes a low net debt to EBITDA ratio of 0.2x for FY25, indicating a strong balance sheet position [7]. Market Position and Strategy - FLSmidth is positioned as a leader in the mining equipment sector, with a focus on enhancing its service offerings and operational efficiency [13]. - The company aims to close the margin gap with its mining equipment peers, which trade at an average EV/EBIT multiple of 14.35x [1]. - The transition to a service-based business model is expected to support higher margins and improved returns on invested capital (ROIC) [33][39].

Investment Rating - The report maintains a "Sell" rating for Acciona Energia with a price target of €18 [1][18][37] Core Views - Consensus earnings estimates for Acciona Energia are considered overly optimistic, particularly regarding the impact of targeted disposals on future profits [1][18] - The company is expected to end 2025 with a smaller installed capacity than in 2024, leading to a year-on-year decline in underlying EBITDA for 2025 and 2026 [1][3][18] - The report forecasts net income for 2025-26 to be approximately 20%-40% below Bloomberg consensus estimates, indicating significant downside risk [4][26][27] Summary by Sections Installed Capacity and Growth - Acciona Energia plans to add 600 MW of capacity organically by 2025, but the announced disposal of 600 MW of domestic hydro assets implies no net growth in installed capacity [2][19] - Incremental divestments of €1.5-1.7 billion are expected, suggesting a minimum reduction of 1 GW in operational assets [2][19] EBITDA and Financial Performance - A decline in underlying EBITDA is anticipated for both 2025 and 2026 due to a shrinking installed base and lower power prices [3][22] - The report projects EBITDA for 2025 at €998 million and for 2026 at €961 million, contrasting with Bloomberg's consensus forecast of a 5%-10% increase in 2026 [3][24] Net Income Forecasts - The report estimates net income for 2025-26 to be around €135-145 million, significantly lower than the consensus estimate of €180-220 million [4][26][27] - This discrepancy suggests a potential for negative EPS revisions, which could further impact the share price [4][26] Valuation and Price Target - The price target of €18 is based on a sum-of-the-parts (SOTP) valuation, with 50% derived from the 2025E SOTP of €19.2/share and 50% from existing asset valuation [37][38] - The report indicates a 2.7% downside from the current price, compared to an average upside of 17% for peers [37][38]

28 May 2025 | 12:07AM AEST Telstra Group (TLS.AX) Buy Monetizing a Connected Future; with 1¢ p.a. DPS growth and A$7-8bn buy-back capacity | | | Telstra hosted its Connected Future 30 Strategy day on 5/27. In our view the two key takeaways from the update are: (1) Telstra has a clear focus on delivering consistent and predictable earnings growth, through simplifying the business, monetizing its core value proposition of superior connectivity, and maintaining tight cost discipline through a commitment to pos ...

Investment Rating - The report does not explicitly state an investment rating for the industry or specific companies Core Insights - Recent sales growth trends for non-alcoholic beverages have decelerated slightly, with overall dollar sales growth up +3.4% year-over-year for the two weeks ending May 17, 2025, compared to previous periods [1] - Pricing growth has softened to +2.7%, while volume growth remains stable at +0.7% year-over-year [1] - Energy drinks continue to show strong sales growth at +8.3% year-over-year, although this is a slight deceleration from previous periods [7] Summary by Category Carbonated Soft Drinks (CSDs) - Dollar sales growth in CSDs was up approximately +LSD% and stable sequentially, with pricing growth slightly stronger but offset by weaker volumes [2] - Coca-Cola Company and Pepsico Inc reported dollar sales growth of +2.7% and +0.3% respectively, with volume declines [9] Bottled Water - Dollar sales trends in bottled water were stable sequentially, with growth around +LSD% and stable pricing and volume growth [2] Energy Drinks - The energy drink category saw dollar sales growth of +8.3% year-over-year, with volume growth at +6.7% [7] - Monster Energy Co. (excluding Bang) reported dollar sales growth of +9.5% year-over-year, driven by stable volume growth [7] Salty Snacks - Dollar sales trends for salty snacks modestly accelerated to -0.9% year-over-year, with volume growth at -2.1% [8] - Pepsico Inc's salty snack sales growth was down -3.3% year-over-year [8] Specific Company Trends - PEP's dollar sales growth modestly accelerated sequentially, while MNST (excluding Bang) showed strong and stable growth at +HSD% [3] - KO's dollar sales growth remained stable at +MSD%, with stable volumes and pricing growth [3] - KDP's dollar sales growth was stable at +LSD%, with stronger pricing growth offset by softer volumes [3]

Investment Rating - The report assigns a "Buy" rating to Ajinomoto with a 12-month target price of ¥4,100, representing an upside of 16.9% from the current price of ¥3,506 [8][10]. Core Insights - Ajinomoto aims to achieve some of its KPIs for 2030 a year ahead of schedule, focusing on cost savings and price hikes while fostering new product development and eliminating sectionalism within the organization [1][6]. - The company expects to achieve its ROE target of 20% in FY3/27 and plans to implement price increases across a wider range of products to secure solid margins [6][9]. - Ajinomoto's overseas sales ratio was 66% in FY3/25, indicating strong international market presence, and the company is well-positioned to benefit from rising demand for seasonings and foods in emerging markets [9]. Summary by Sections 2030 Roadmap - Ajinomoto is targeting to achieve certain KPIs ahead of schedule, including an improved EBITDA margin through expansion into neighboring markets and organic growth [6]. Profitability Improvement Initiatives - The company plans to implement price increases across various product lines while focusing on cost reductions to maintain profitability [6]. FY3/26 Guidance - Ajinomoto believes it can meet its FY3/26 guidance for ABF, which performed well in FY3/25, and acknowledges challenges in achieving significant profit increases in the CDMO segment [6]. New Products and Services - The company has not launched major new products since ABF but is motivated to innovate, with improved cooperation between internal organizations noted as a positive change [6][7]. High-Speed R&D System - Ajinomoto's R&D system focuses on understanding customer needs and completing products ahead of demand, which has been successfully applied in both electronic materials and the food business [7]. CDMO Business Model - Ajinomoto operates an asset-light CDMO business model, leveraging technological advantages to earn licensing income with minimal investment [7]. Valuation Methodology - The target price of ¥4,100 is based on an average EV/NOPAT multiple of 26X for FY3/26E-FY3/27E, reflecting an 18% premium to the sector average [8].

Investment Rating - The investment rating for Shennan Circuits is "Buy" with a 12-month target price of Rmb152, indicating a potential upside of 40% from the current price of Rmb108.6 [9][12]. Core Insights - Shennan Circuits is positioned as a key supplier in the high-end PCB market in China, benefiting from domestic AI infrastructure investments, which are expected to drive robust revenue and net profit growth [9]. - The company is experiencing a strong demand for AI-related products, with overall PCB capacity utilization exceeding 90% and AI-related capacity running at full production [3][9]. - The ABF business is in the early ramp-up stage, with expectations of narrowing losses in 2025 due to cost control and increased revenue [4][9]. Summary by Sections Raw Material Costs - Raw material costs, particularly for gold and copper-related materials, are on the rise, prompting Shennan to negotiate prices with suppliers. Gold-related materials account for less than 10% of total procurement [2][9]. - Management plans to pass some of the cost increases to customers due to high overall demand and utilization levels [2]. PCB Outlook - The demand for PCBs is robust, driven by local AI needs, including AI accelerators and high-speed optical transceivers. This demand is expected to improve the product mix and gross margin outlook into 2Q~3Q25 [3][9]. ABF Business Status - The Guangzhou ABF plant reported a pre-tax loss of Rmb550 million in 2024, but management anticipates a reduction in losses for 2025, projecting revenues of over Rmb100 million [4][9]. - Monthly depreciation costs are expected to remain below Rmb30 million, with current costs at Rmb25 million [6][9]. Financial Projections - Revenue projections show a growth trajectory from Rmb17,907 million in 2024 to Rmb26,694 million by 2027, with net income expected to rise from Rmb1,879 million in 2024 to Rmb4,014 million in 2027 [7][12].

Investment Rating - The report maintains a "Buy" rating for China Life H, Ping An, and upgrades PICC P&C to "Buy" from "Neutral" [3][7]. Core Insights - Chinese insurers have outperformed the HSI/CSI300 indices since early March, primarily due to fund-flow related factors and expectations of increased inflows into the A-share market [1][8]. - Despite recent share price strength, most insurers are trading at or above 1 standard deviation of their 3-year historical P/B, indicating potential near-term downside risks due to challenging fundamentals [2][8]. - There has been a tangible improvement in shareholder returns, with several insurers announcing stable or progressive dividend targets and considering share buybacks, aligning with government objectives to enhance SOE valuations [3][43]. Summary by Sections Investment Ratings and Price Targets - The report raises FY25E EPS estimates by 3-46% for covered companies, reflecting better-than-expected 1Q25 results and equity market performance [4][56]. - Target prices for PICC P&C are raised to HK$16.10 from HK$12.90, implying a 1.1X FY26E P/B and 9.8X FY26E P/E [4][57]. - Target prices for PICC Group H/A are increased by 20%/11% to reflect new valuations for PICC P&C, while other life insurers see target price increases of 4-10% [4][57]. Market Performance and Valuation - H-share insurers have outperformed since early March by more than 10%, although YTD performance remains relatively unchanged compared to indices [8][9]. - The report notes that long-term bond yields have remained depressed, impacting book value and solvency, with a decline in net investment yield expected due to muted equity market performance [2][25][27]. Shareholder Returns and Capital Management - Several insurers have announced plans for stable or progressive dividends and share buybacks, with PICC P&C positioned to increase shareholder returns due to an excess capital balance of RMB 47 billion as of FY24 [3][43][51]. - China Life is highlighted as having a strong balance sheet but a low current payout ratio, indicating potential for increased shareholder returns [3][43]. Earnings and Profitability Outlook - The report anticipates muted book value growth in 2Q25, with long-term bond yields declining to levels seen at the end of 2024 [27][56]. - Net profit for most life insurers declined in 1Q25, reflecting lower equity investment gains compared to 1Q24, with expectations for small profit growth in 2Q25 but a meaningful year-over-year decline for FY25 [27][38].

Investment Rating - Sawai Group is rated as "Sell" with a 12-month target price of ¥1,650 [2][14] - Toray is rated as "Buy" with a 12-month target price of ¥1,300 [3][15] Core Insights - The Intellectual Property High Court (IPHC) has ordered Sawai Pharmaceutical to pay ¥14.3 billion in damages for patent infringement related to the pruritus treatment Remitch [1][8] - The ruling is expected to negatively impact Sawai Group's share price due to the realization of compensation payment risks and potential strategic implications for its market share growth [2][12] - For Toray, the ruling is seen as a significant win for its intellectual property strategy, potentially leading to a positive impact on its profit and cash flow if compensation is received [3][11] Summary by Sections Sawai Group - The company plans to restate its FY3/25 earnings due to the ruling, with the impact on earnings currently being assessed [8] - Sawai intends to appeal the ruling and is considering all legal measures [8][9] - The ruling may affect Sawai's strategy of increasing market share through its intellectual property and drug formulation technology [12] Toray - The total compensation ordered against Sawai and Fuso Pharmaceutical amounts to ¥21.7 billion, with Toray potentially receiving ¥21.7 billion [11] - The ruling reinforces the strength of Toray's intellectual property strategy and could lead to a considerable impact on its earnings, given its projected net profits of ¥82 billion for FY3/26 [11]